このエントリーをはてなブックマークに追加
ID 53537
Sort Key
9
Title Alternative
A prospective cohort study to define the clinical and pathological features of lung cancers harboring HER2 gene aberrations (the HER2-CS Study) and a phase II study of trastuzumab emtansine (recombinant) in patients with HER2-positive non-small cell lung cancer who recurred, progressed after standard chemotherapy, or were primarily refractory to standard chemotherapy
FullText URL
127_127.pdf 1.69 MB
Author
Sato, Akiko
Ninomiya, Takashi
Minnami, Daisuke
Tabata, Masahiro Kaken ID researchmap
Kubo, Toshio Kaken ID researchmap
Kato, Yuka Kaken ID
Hirata, Taizo
Keywords
臨床研究中核病院
国立研究開発法人日本医療研究開発機構
文部科学省橋渡し研究加速ネットワークプログラム
HER2-CS study
trastuzumab emtansine
Note
特集(Feature Articles)
Publication Title
岡山医学会雑誌
Published Date
2015-08-03
Volume
volume127
Issue
issue2
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
127
End Page
132
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
Related Url
isVersionOf https://doi.org/10.4044/joma.127.127
OAI-PMH Set
岡山大学
language
日本語
Copyright Holders
Copyright (c) 2015 岡山医学会
File Version
publisher
Refereed
True
DOI
NAID
Eprints Journal Name
joma